The role of red blood cell deformability and Na, K-atpase function in selected risk factors of cardiovascular diseases in humans: Focus on hypertension, diabetes mellitus and hypercholesterolemia

Physiological Research

Volumn 65, Issue , 2016, Pages S43-S54

  Radosinska, J ^a,b   Vrbjar, N ^b  

^a Physics and Informatics   (Slovakia)

^b INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Cardiovascular risk factors; Erythrocyte deformability; Na,K ATPase

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM);

BLOOD; CYTOLOGY; DIABETES MELLITUS; ENZYMOLOGY; ERYTHROCYTE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; METABOLISM; RISK FACTOR;

DIABETES MELLITUS; ERYTHROCYTES; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; RISK FACTORS; SODIUM-POTASSIUM-EXCHANGING ATPASE;

EID: 84997142694     PISSN: 08628408     EISSN: 18029973     Source Type: Journal    
DOI: 10.33549/physiolres.933402     Document Type: Review

References (92)

1. AMAIDEN MR, SANTANDER VS, MONESTEROLO NE, CAMPETELLI AN, RIVELLI JF, PREVITALI G, ARCE CA, CASALE CH: Tubulin pools in human erythrocytes: altered distribution in hypertensive patients affects Na+, K+-ATPase activity. Cell Mol Life Sci 68: 1755-1768, 2011.
2. +-ATPase activity and erythrocyte function in hypertensive subjects. FEBS Lett 589: 364-373, 2015.
3. BABA Y, KAI M, KAMADA T, SETOYAMA S, OTSUJI S: Higher levels of erythrocyte membrane microviscosity in diabetes. Diabetes 28: 1138-1140, 1979.
4. BOR-KUCUKATAY M, WENBY RB, MEISELMAN HJ, BASKURT OK: Effects of nitric oxide on red blood cell deformability. Am J Physiol Heart Circ Physiol 284: H1577-H1584, 2003.
5. BRONCEL M, BALA A, KOTER-MICHALAK M, DUCHNOWICZ P, WOJSZNIS W, CHOJNOWSKAJEZIERSKA J: Physicochemical modifications induced by statins therapy on human erythrocytes membranes. Wiad Lek 60: 321-328, 2007.
6. BUYS AV, VAN ROOY MJ, SOMA P, VAN PAPENDORP D, LIPINSKI B, PRETORIUS E: Changes in red blood cell membrane structure in type 2 diabetes: a scanning electron and atomic force microscopy study. Cardiovasc Diabetol 12: 25, 2013.
7. CARVALHO FA, MARIA AV, BRAZ NOGUEIRA JM, GUERRA J, MARTINS-SILVA J, SALDANHA C: The relation between the erythrocyte nitric oxide and hemorheological parameters. Clin Hemorheol Microcirc 35: 341-347, 2006.
8. CHABANEL A, FLAMM M, SUNG KLP, LEE MM, SCHACHTER D, CHIEN S: Influence of cholesterol content on red cell membrane viscoelasticity and fluidity. Biophys J 44: 171-176, 1983.
9. CHAKRABORTY A, CHOWDHURY S, BHATTACHARYYA M: Effect of metformin on oxidative stress, nitrosative stress and inflammatory biomarkers in type 2 diabetes patients. Diabetes Res Clin Pract 93: 56-62, 2011.
10. CICCO G, CARBONARA MC, STINGI GD, PIRRELLI A: Cytosolic calcium and hemorheological patterns during arterial hypertension. Clin Hemorheol Microcirc 24: 25-31, 2001.
11. COOPER RA, ARNER EC, WILEY JS, SHATTIL SJ: Modification of red cell membrane structure by cholesterol-rich lipid dispersions. A model for the primary spur cell defect. J Clin Invest 55: 115-126, 1975.
12. DAVID-DUFILHO M, ASTARIE C, PERNOLLET MG, DEL PINO M, LEVENSON J, SIMON A, DEVYNCK MA: Control of the erythrocyte free Ca2+ concentration in essential hypertension. Hypertension 19: 167-174, 1992.
13. DE LA TOUR DD, RACCAH D, JANNOT MF, COSTE T, ROUGERIE C, VAGUE P: Erythrocyte Na/K ATPase activity and diabetes: relationship with C-peptide level. Diabetologia 41: 1080-1084, 1998.
14. DEVYNCK MA, PERNOLLET MG, MEYER P: Endogenous digitalis-like compounds in essential and experimental hypertension. Int J Rad Appl Instrum B 14: 341-352, 1987.
15. DITZEL J, STANDL E: The problem of tissue oxygenation in diabetes mellitus. Acta Med Scand Suppl 578: 59-68, 1975.
16. DITZEL J, JAEGER P, STANDL E: An adverse effect of insulin on the oxygen-release capacity of red blood cells in nonacidotic diabetics. Metabolism 27: 927-934, 1978.
17. DUCHNOWICZ P, NOWICKA A, KOTER-MICHALAK M, BRONCEL M: In vivo influence of extract from Aronia melanocarpa on the erythrocyte membranes in patients with hypercholesterolemia. Med Sci Monit 18: CR569-CR574, 2012.
18. EJIMA J, IJICHI T, OHNISHI Y, MARUYAMA T, KAJI Y, KANAYA S, FUJINO T, UYESAKA N, OHMURA T: Relationship of high-density lipoprotein cholesterol and red blood cell filterability: cross-sectional study of healthy subjects. Clin Hemorheol Microcirc 22: 1-7, 2000.
19. ELIMBAN V, BARTEKOVA M, XU YJ, DHALLA NS: Regulation of membrane Na+-K+ ATPase in health and disease. In: Advances in Biochemistry in Health and Disease. S CHAKRABORTI, NS DHALLA (eds), Springer, New York, 2016, vol 15, pp 311-322.
20. ERCAN M, KONUKOGLU D, ERDEM T, ONEN S: The effects of cholesterol levels on hemorheological parameters in diabetic patients. Clin Hemorheol Microcirc 26: 257-263, 2002.
21. FALOIA E, GARRAPA GG, MARTARELLI D, CAMILLONI MA, LUCARELLI G, STAFFOLANI R, MANTERO F, CURATOLA G, MAZZANTI L: Physicochemical and functional modifications induced by obesity on human erythrocyte membranes. Eur J Clin Invest 29: 432-437, 1999.
22. FORNAL M, KORBUT RA, KROLCZYK J, GRODZICKI T: Left ventricular geometry and rheological properties of erythrocytes in patients at cardiovascular disease risk. Clin Hemorheol Microcirc 43: 203-208, 2009.
23. FORNAL M, KORBUT RA, KROLCZYK J, GRODZICKI T: Evolution of rheological properties of erythrocytes and left ventricular geometry in cardiovascular disease risk patients. Clin Hemorheol Microcirc 45: 155-159, 2010.
24. FORNAL M, KORBUT RA, GRODZICKI T: Relevance of erythrocyte deformability to the concentration of soluble cell adhesion molecules and glomerular filtration rate in patients with untreated essential hypertension. Clin Hemorheol Microcirc 49: 323-329, 2011.
25. FORST T, KUNT T: Effects of C-peptide on microvascular blood flow and blood hemorheology. Exp Diabesity Res 5: 51-64, 2004.
26. FORST T, WEBER MM, LOBIG M, LEHMANN U, MULLER J, HOHBERG C, FRIEDRICH C, FUCHS W, PFUTZNER A: Pioglitazone in addition to metformin improves erythrocyte deformability in patients with Type 2 diabetes mellitus. Clin Sci (Lond) 119: 345-351, 2010.
27. GARDNER K, BENNETT V: A new erythrocyte membrane associated protein with calmodulin binding activity. Identification and purification. J Biol Chem 261: 1339-1348, 1986.
28. GOI G, CAZZOLA R, TRINGALI C, MASSACCESI L, VOLPE SR, RONDANELLI M, FERRARI E, HERRERA CJ, CESTARO B, LOMBARDO A, VENERANDO B: Erythrocyte membrane alterations during ageing affect beta-D-glucuronidase and neutral sialidase in elderly healthy subjects. Exp Gerontol 40: 219-225, 2005.
29. GOODMAN SR, KURDIA A, AMMANN L, KAKHNIASHVILI D, DAESCU O: The human red blood cell proteome and interactome. Exp Biol Med (Maywood) 232: 1391-1408, 2007.
30. HACH T, FORST T, KUNT T, EKBERG K, PFUTZNER A, WAHREN J: C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients. Exp Diabetes Res 2008: 730594, 2008.
31. HOOGWERF BJ, BANTLE JP, GAENSLEN HE, GREENBERG BZ, SENSKE BJ, FRANCIS R, GOETZ FC: Infusion of synthetic human C-peptide does not affect plasma glucose, serum insulin, or plasma glucagon in healthy subjects. Metabolism 35: 122-125, 1986.
32. HOSSMANN V, BONNER G, WAMBACH G, LAASER U, KAUFMANN W: Blood viscosity: a pathogenetic factor in the development of essential hypertension? Clin Exp Hypertens A 8: 673-680, 1986.
33. HUANG YX, WU ZJ, MEHRISHI J, HUANG BT, CHEN XY, ZHENG XJ, LIU WJ, LUO M: Human red blood cell aging: correlative changes in surface charge and cell properties. J Cell Mol Med 15: 2634-2642, 2011.
34. JAIN SK, LIM G: Lipoic acid decreases lipid peroxidation and protein glycosylation and increases (Na(+) + K(+))-and Ca(++)-ATPase activities in high glucose-treated human erythrocytes. Free Radic Biol Med 29: 1122-1128, 2000.
35. JANNOT MF, RACCAH D, DE LA TOUR DD, COSTE T, VAGUE P: Genetic and environmental regulation of Na/K adenosine triphosphatase activity in diabetic patients. Metabolism 51: 284-291, 2002.
36. JUBELIN BC, GIERMAN JL: Erythrocytes may synthesize their own nitric oxide. Am J Hypertens 9: 1214-1219, 1996.
37. JUHAN-VAGUE I, ROUL C, RAHMANI-JOURDHEIL D, MISHAL Z, DRISS F, DURAND-GASSELIN M, AILLAUD MF, VAGUE P: Rapid modifications of biophysical and biochemical parameters of red blood cell membrane from insulin dependent diabetics after insulin administration. Klin Wochenschr 64: 1046-1049, 1986.
38. KAMENEVA MV, WATACH MJ, BOROVETZ HS: Gender difference in rheologic properties of blood and risk of cardiovascular diseases. Clin Hemorheol Microcirc 21: 357-363, 1999.
39. KAZENNOV AM, MASLOVA MN, SHALABODOV AD, BAGROV JYU, GUREVICH VS: Some properties of erythrocyte Na+-K+-ATPase in essential hypertension. Clin Exp Hypertens A 9: 1221-1232, 1987.
40. KAZENNOV AM, ULIANOVA TP, GANELINA IE, GUSEV GP, KRUCHININA NA, MASLOVA MN: Ionic homeostasis and erythrocyte deformability in patients with primary arterial hypertension. Kardiologiia 30: 19-22, 1990.
41. KITABCHI AE: The biological and immunological properties of pork and beef insulin, proinsulin, and connecting peptides. J Clin Invest 49: 979-987, 1970.
42. KOHNO M, MURAKAWA K, YASUNARI K, YOKOKAWA K, HORIO T, KANO H, MINAMI M, YOSHIKAWA J: Improvement of erythrocyte deformability by cholesterol-lowering therapy with pravastatin in hypercholesterolemic patients. Metabolism 46: 287-291, 1997.
43. KORBUT R, GRYGLEWSKI RJ: Nitric oxide from polymorphonuclear leukocytes modulates red blood cell deformability in vitro. Eur J Pharmacol 234: 17-22, 1993.
44. KOTER M, BRONCEL M, CHOJNOWSKA-JEZIERSKA J, KLIKCZYNSKA K, FRANIAK I: The effect of atorvastatin on erythrocyte membranes and serum lipids in patients with type-2 hypercholesterolemia. Eur J Clin Pharmacol 58: 501-506, 2002.
45. KOTER M, FRANIAK I, BRONCEL M, CHOJNOWSKA-JEZIERSKA J: Effects of simvastatin and pravastatin on peroxidation of erythrocyte plasma membrane lipids in patients with type 2 hypercholesterolemia. Can J Physiol Pharmacol 81: 485-492, 2003.
46. KOTER M, FRANIAK I, STRYCHALSKA K, BRONCEL M, CHOJNOWSKA-JEZIERSKA J: Damage to the structure of erythrocyte plasma membranes in patients with type-2 hypercholesterolemia. Int J Biochem Cell Biol 36: 205-215, 2004.
47. KUNT T, SCHNEIDER S, PFüTZNER A, GOITUM K, ENGELBACH M, SCHAUF B, BEYER J, FORST T: The effect of human proinsulin C-peptide on erythrocyte deformability in patients with Type I diabetes mellitus. Diabetologia 42: 465-471, 1999.
48. LE DEVEHAT C, KHODABANDEHLOU T, VIMEUX M: Relationship between hemorheological and microcirculatory abnormalities in diabetes mellitus. Diabete Metab 20: 401-404, 1994.
49. +-ATPase activity and increased plasma TBARS in prehypertensive patients. ScientificWorldJournal 2012: 348246, 2012.
50. MANZELLA D, RAGNO E, ABBATECOLA AM, GRELLA R, PAOLISSO G: Residual C-peptide secretion and endothelial function in patients with Type II diabetes. Clin Sci (Lond) 105: 113-118, 2003.
51. MARTINEZ M, VAYA A, GIL L, MARTI R, DALMAU J, AZNAR J: The cholesterol/phospholipid ratio of the erythrocyte membrane in children with familial hypercholesterolemia. Its relationship with plasma lipids and red blood cell aggregability. Clin Hemorheol Microcirc 18: 259-263, 1998.
52. MASUYAMA Y, TSUDA K, SHIMA H, URA M, TAKEDA J, KIMURA K, NISHIO I: Membrane abnormality of erythrocytes is highly dependent on salt intake and renin profile in essential hypertension: an electron spin resonance study. J Hypertens Suppl 6: S266-S268, 1988.
53. MATURU P, VADDI DR, PANNURU P, NALLANCHAKRAVARTHULA V: Alterations in erythrocyte membrane fluidity and Na+/K+-ATPase activity in chronic alcoholics. Mol Cell Biochem 339: 35-42, 2010.
54. MAURYA PK, PRAKASH S: Decreased activity of Ca(++)-ATPase and Na(+)/K(+)-ATPase during aging in humans. Appl Biochem Biotechnol 170: 131-137, 2013.
55. MCMILLAN DE: Deterioration of the microcirculation in diabetes. Diabetes 24: 944-957, 1975.
56. MOKKEN FC, KEDARIA M, HENNY CP, HARDEMAN MR, GELB AW: The clinical importance of erythrocyte deformability, a hemorrheological parameter. Ann Hematol 64: 113-122, 1992.
57. NAGAI Y, ISHIDA K, HIROOKA M, NISHIMARU K: Effect of ethanol on hemorheology in patients with ischemic cerebrovascular disease and elderly healthy men. Clin Hemorheol Microcirc 25: 135-144, 2001.
58. NAMAZI G, JAMSHIDI RAD S, ATTAR AM, SARRAFZADEGAN N, SADEGHI M, NADERI G, POURFARZAM M: Increased membrane lipid peroxidation and decreased Na+/K+-ATPase activity in erythrocytes of patients with stable coronary artery disease. Coron Artery Dis 26: 239-244, 2015.
59. NIGRA AD, MONESTEROLO NE, RIVELLI JF, AMAIDEN MR, CAMPETELLI AN, CASALE CH, SANTANDER VS: Alterations of hemorheological parameters and tubulin content in erythrocytes from diabetic subjects. Int J Biochem Cell Biol 74: 109-120, 2016.
60. ODASHIRO K, SAITO K, ARITA T, MARUYAMA T, FUJINO T, AKASHI K: Impaired deformability of circulating erythrocytes obtained from nondiabetic hypertensive patients: investigation by a nickel mesh filtration technique. Clin Hypertens 21: 17, 2015.
61. OTTO C, GEISS HC, LAUBACH E, SCHWANDT P: Effects of direct adsorption of lipoproteins apheresis on lipoproteins, low-density lipoprotein subtypes, and hemorheology in hypercholesterolemic patients with coronary artery disease. Ther Apher 6: 130-135, 2002.
62. PADMAVATHI P, REDDY VD, KAVITHA G, PARAMAHAMSA M, VARADACHARYULU N: Chronic cigarette smoking alters erythrocyte membrane lipid composition and properties in male human volunteers. Nitric Oxide 23: 181-186, 2010.
63. PASQUALI, STROCCHI E, MALINI P, CASIMIRRI F, MELCHIONDA N, AMBROSIONI E, LABO G: Heterogeneity of the erythrocyte Na-K pump status in human obesity. Metabolism 34: 802-807, 1985.
64. PASQUALI R, CESARI MP, MELCHIONDA N, BOSCHI S, MUNARINI A, BARBARA L: Erythrocyte Na-KATPase membrane activity in obese patients fed over a long-term period with a very-low-calorie diet. Metabolism 37: 86-90, 1988.
65. PENCO M, ROMANO S, DAGIANTI A JR, TOZZI-CIANCARELLI MG, DAGIANTI A: Modifications of whole blood filterability during acute myocardial infarction. Clin Hemorheol Microcirc 22: 153-159, 2000.
66. PUSL T, BROEDL UC, PARHOFER KG, OTTO C: Long-term LDL apheresis does not stably improve hemorheology in hypercholesterolemic patients with coronary artery disease. Clin Hemorheol Microcirc 41: 137-142, 2009.
67. PYTEL E, DUCHNOWICZ P, JACKOWSKA P, WOJDAN K, KOTER-MICHALAK M, BRONCEL M: Disorders of erythrocyte structure and function in hypertensive patients. Med Sci Monit 18: BR331-BR336, 2012.
68. PYTEL E, OLSZEWSKA-BANASZCZYK M, KOTER-MICHALAK M, BRONCEL M: Increased oxidative stress and decreased membrane fluidity in erythrocytes of CAD patients. Biochem Cell Biol 91: 315-318, 2013.
69. RILLAERTS E, VAN GAAL L, XIANG DZ, VANSANT G, DE LEEUW I: Blood viscosity in human obesity: relation to glucose tolerance and insulin status. Int J Obes 13: 739-745, 1989.
70. RIVELLI JF, AMAIDEN MR, MONESTEROLO NE, PREVITALI G, SANTANDER VS, FERNANDEZ A, ARCE CA, CASALE CH: High glucose levels induce inhibition of Na,K-ATPase via stimulation of aldose reductase, formation of microtubules and formation of an acetylated tubulin/Na,K-ATPase complex. Int J Biochem Cell Biol 44: 1203-1213, 2012.
71. RODRIGO R, MIRANDA-MERCHAK A, VALENZUELA GRAU R, BACHLER JP, VERGARA L: Modulation of (Na,K)-ATPase activity by membrane fatty acid composition: therapeutic implications in human hypertension. Clin Exp Hypertens 36: 17-26, 2014.
72. SAKLAMAZ A, COMLEKCI A, TEMIZ A, CALISKAN S, CEYLAN C, ALACACIOGLU A, YESIL S: The beneficial effects of lipid-lowering drugs beyond lipid-lowering effects: a comparative study with pravastatin, atorvastatin, and fenofibrate in patients with type IIa and type IIb hyperlipidemia. Metabolism 54: 677-681, 2005.
73. SCHMID-SCHONBEIN H: Microrheology of erythrocytes, blood viscosity, and the distribution of blood flow in the microcirculation. Int Rev Physiol 9: 1-62, 1976.
74. SCHMID-SCHONBEIN H, VOLGER E: Red-cell aggregation and red-cell deformability in diabetes. Diabetes 25: 897-902, 1976.
75. SOLA E, VAYA A, SANTAOLARIA ML, HERNANDEZ-MIJARES A, REGANON E, VILA V, MARTINEZSALES V, CORELLA D: Erythrocyte deformability in obesity measured by ektacytometric techniques. Clin Hemorheol Microcirc 37: 219-227, 2007.
76. SOSZYNSKI M, BARTOSZ G: Decrease in accessible thiols as an index of oxidative damage to membrane proteins. Free Radic Biol Med 23: 463-469, 1997.
77. SZAPARY L, HORVATH B, MARTON Z, ALEXY T, KESMARKY G, HABON T, SZOTS M, KOLTAI K, JURICSKAY I, CZOPF J, TOTH K: Short-term effect of low-dose atorvastatin on haemorrheological parameters, platelet aggregation and endothelial function in patients with cerebrovascular disease and hyperlipidaemia. CNS Drugs 18: 165-172, 2004.
78. TOMAIUOLO G: Biomechanical properties of red blood cells in health and disease towards microfluidics. Biomicrofluidics 8: 051501, 2014.
79. TOTH A, PAPP J, RABAI M, KENYERES P, MARTON Z, KESMARKY G, JURICSKAY I, MEISELMAN HJ, TOTH K: The role of hemorheological factors in cardiovascular medicine. Clin Hemorheol Microcirc 56: 197-204, 2014.
80. TSUDA K: Adiponectin and membrane fluidity of erythrocytes in normotensive and hypertensive men. Obesity (Silver Spring) 14: 1505-1510, 2006.
81. TSUDA K: Roles of adiponectin and oxidative stress in the regulation of membrane microviscosity of red blood cells in hypertensive men - an electron spin resonance study. J Obes 2011: 548140, 2011.
82. +-adenosine triphosphatase inhibitory factor in the regulation of membrane fluidity of erythrocytes in essential hypertension. J Hypertens 10: 657-661, 1992.
83. TSUDA K, KIMURA K, NISHIO I, MASUYAMA Y: Nitric oxide improves membrane fluidity of erythrocytes in essential hypertension: an electron paramagnetic resonance investigation. Biochem Biophys Res Commun 275: 946-954, 2000.
84. TSUDA K, KINOSHITA Y, NISHIO I, MASUYAMA Y: Hyperinsulinemia is a determinant of membrane fluidity of erythrocytes in essential hypertension. Am J Hypertens 14: 419-423, 2001.
85. TSUDA K, KINOSHITA-SHIMAMOTO Y, MABUCHI Y, NISHIO I: Hormone replacement therapy improves membrane fluidity of erythrocytes in postmenopausal women: an electron paramagnetic resonance investigation. Am J Hypertens 16: 502-507, 2003.
86. VAGUE P, JUHAN I: Red cell deformability, platelet aggregation, and insulin action. Diabetes 32: 88-91, 1983.
87. VAGUE P, DUFAYET D, COSTE T, MORISCOT C, JANNOT MF, RACCAH D: Association of diabetic neuropathy with Na/K ATPase gene polymorphism. Diabetologia 40: 506-511, 1997.
88. VAYA A, MARTINEZ M, GUILLEN M, DALMAU J, AZNAR J: Erythrocyte deformability in young familial hypercholesterolemics. Clin Hemorheol Microcirc 19: 43-48, 1998.
89. WAMBACH G, OVERHOFF U, HOSSMANN V: Sodium transport and red cell deformability. Klin Wochenschr 63: 35-37, 1985.
90. WATALA C, WITAS H, OLSZOWSKA L, PIASECKI W: The association between erythrocyte internal viscosity, protein non-enzymatic glycosylation and erythrocyte membrane dynamic properties in juvenile diabetes mellitus. Int J Exp Pathol 73: 655-663, 1992.
91. ZHAO GS, LI DY, ZHU DL, KONG DW, QIAN YW, LI DP: Cellular mechanism relating sodium and potassium to hypertension. Ann Clin Res 16: 55-61, 1984.
92. ZIOBRO A, DUCHNOWICZ P, MULIK A, KOTER-MICHALAK M, BRONCEL M: Oxidative damages in erythrocytes of patients with metabolic syndrome. Mol Cell Biochem 378: 267-273, 2013.